Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

1,079.00p
   
  • Change Today:
    -5.50p
  • 52 Week High: 1,417.50
  • 52 Week Low: 982.40
  • Currency: UK Pounds
  • Shares Issued: 837.43m
  • Volume: 2,539,516
  • Market Cap: £9,036m
  • RiskGrade: 173

Smith and Nephew Overview

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. It operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue.

1 Day Chart (19-10-2026)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Smith and Nephew Financials

Latest F'cast
Div Yield 2.5% 0.0%
Div Cover 2.6 3.0
Op Mrgn 12.9% 17.1%
ROCE 16.4%  
Latest F'cast
P/E 15.2 15.7
PEG 0.7 1.2
Pr/Revenue 2.1 1.8
Pr/Book 2.5  
Latest F'cast
Revenue 6.1% -21.1%
PBT 56.4% 6.9%
EPS 21.0% -11.9%
DPS 4.3% -41.7%

Smith and Nephew Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 5,212.00 586.00 80.90¢ 21.3 0.9 +25% 37.50¢ 2.2%
31-Dec-22 5,215.00 235.00 81.80¢ 18.0 18.0 +1% 37.50¢ 2.5%
31-Dec-23 5,549.00 290.00 82.80¢ 17.3 17.3 +1% 37.50¢ 2.6%
31-Dec-24 5,810.00 498.00 84.30¢ 15.6 7.8 +2% 37.50¢ 2.8%
31-Dec-25 6,164.00 779.00 102.00¢ 16.2 0.8 +21% 39.10¢ 2.4%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Smith and Nephew Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 6,470.88 1,108.52 89.84p 12.1 n/a -12% 30.36p 0.0%
31-Dec-27 6,808.20 1,214.18 98.14p 11.1 1.2 +9% 32.69p 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Smith and Nephew Company Announcements

Notice of Results 08-Oct-2026 14:27 RNS
Total Voting Rights 01-Oct-2026 10:03 RNS
Redemption Price of $350m 5.150% Notes due 2027 01-Oct-2026 07:00 RNS

Smith and Nephew ShareCast News

Smith & Nephew CFO John Rogers to step down 19-Aug-2026 ShareCast
Smith & Nephew lifts H1 profits, lowers FY reven... 04-Aug-2026 ShareCast
Smith & Nephew trades in line during Q1, reitera... 06-May-2026 ShareCast

Smith and Nephew Top Newspaper Links

Smith & Nephew finance chief abruptly quits for ... 19-Aug-2026 Times
Festive cheer for Smith & Nephew as shares jump ... 26-Dec-2014 Daily Mail
Smith & Nephew shares jump 10pc on Stryker bid r... 26-Dec-2014 Telegraph

Latest Smith and Nephew Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Smith and Nephew Market Data

Currency UK Pounds
Share Price 1,079.00p
Change Today -5.50p
% Change -0.51 %
52 Week High 1,417.50
52 Week Low 982.40
Volume 2,539,516
Shares Issued 837.43m
Market Cap £9,036m
RiskGrade 173

Smith and Nephew Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
83.02% below the market average83.02% below the market average83.02% below the market average83.02% below the market average83.02% below the market average
92.31% above the sector average92.31% above the sector average92.31% above the sector average92.31% above the sector average92.31% above the sector average
Price Trend
18.56% above the market average18.56% above the market average18.56% above the market average18.56% above the market average18.56% above the market average
72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average
Income
42.26% below the market average42.26% below the market average42.26% below the market average42.26% below the market average42.26% below the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
66.16% above the market average66.16% above the market average66.16% above the market average66.16% above the market average66.16% above the market average
21.43% above the sector average21.43% above the sector average21.43% above the sector average21.43% above the sector average21.43% above the sector average

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 11
Sell 2
Strong Sell 0
Total 16
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith and Nephew Dividends

  Latest Previous
  Interim Final
Ex-Div 01-Oct-26 26-Mar-26
Paid 06-Nov-26 27-May-26
Amount 15.60¢ 24.10¢

Trades for 19-Oct-2026

Time Volume / Share Price
16:35 697,032 @ 1,079.00p
16:35 3,263 @ 1,079.00p
16:35 819 @ 1,079.00p
16:35 818 @ 1,079.00p
16:35 112 @ 1,079.00p

Smith and Nephew Key Personnel

CEO Deepak Nath

Top of Page